Growth Medium Selection and Its Economic Impact on Plasmid DNA Production

Journal of Bioscience and Bioengineering

Volumn 104, Issue 6, 2007, Pages 490-497

  Danquah, Michael K ^a   Forde, Gareth M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

cultivation medium; fermentation; plasmid DNA

Indexed keywords

CELL CULTURE; ECONOMIC ANALYSIS; ESCHERICHIA COLI; FERMENTATION; STOICHIOMETRY; VACCINES;

CULTIVATION MEDIUM; DRY CELL MASS; PLASMID DNA; STOICHIOMETRICALLY-FORMULATED MEDIUM;

DNA;

CARBON; NITROGEN; PLASMID DNA;

ARTICLE; BACTERIUM CULTURE; CULTURE MEDIUM; DNA DETERMINATION; DNA VECTOR; DRY MASS; ECONOMIC ASPECT; ESCHERICHIA COLI; FERMENTATION; INNER CELL MASS; NONHUMAN; PLASMID; QUANTUM YIELD; SPECIES CULTIVATION; STANDARD; STOICHIOMETRY; VOLUMETRY;

AUSTRALIA; CELL CULTURE TECHNIQUES; DNA, BACTERIAL; ESCHERICHIA COLI; INDUSTRIAL MICROBIOLOGY; PLASMIDS;

ESCHERICHIA COLI;

EID: 38149049119     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.104.490     Document Type: Article

References (22)

1. Durland R.H., and Eastman E.M. Manufacturing and quality control of plasmid-based gene expression systems. Adv. Drug Deliv. Rev. 30 (1998) 33-48
2. Prather K.J., Sagar S., Murphy J., and Chartrain M. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production and purification. Enzyme Microb. Technol. 33 (2003) 865-883
3. Prazeres D., Ferreira G.N.M., Monteiro G.A., Cooney C.L., and Cabral J.M.S. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol. 17 (2003) 169-174
4. Wang Z., Le G., Shi W., and Wegrzyn G. Medium design for plasmid DNA production based on stoichiometric model. Process Biochem. 36 (2001) 1085-1093
5. Mor G. Plasmid DNA, a new era in vaccinology. Biochem. Pharm. 55 (1998) 1151-1153
6. Butts C., Zubkoff I., and Robbins D.S. DNA immunization of infants: potential and limitations. Vaccine 16 (1998) 1444-1449
7. Schodel F., Aguado M.T., and Lambert P.H. Introduction: nucleic acid vaccine, WHO, Geneva. Vaccine 12 (1994) 1491-1492
8. O'Kennedy R., Ward J., and Keshavarz-Moore E. Effect of fermentation strategy on the characteristics of plasmid DNA production. Biotechnol. Appl. Biochem. 37 (2003) 83-90
9. Stanier R.Y., Doudoroff M., and Adelberg E.A. The microbial world. 3rd ed. (1976), Prentice Hall, Englewood Cliffs, NJ
10. West-Robert C. Handbook of chemistry and physics. 60th ed. (1979), CRC Press, Boca Raton, Florida
11. Makrides S. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60 (1996) 512-538
12. Balbas P., and Bolivar F. Design and construction of expression plasmid vectors in Escherichia coli. Methods Enzymol. 185 (1990) 14-37
13. Venetianer P. Possibilities of increasing the expression of cloned foreign genes in Escherichia coli. Acta Biotechnol. 11 (1991) 129-133
14. Riesenberg D., Menzel K., Schultz V., Schumann K., Veith G., and Zuber G. High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 34 (1990) 77-82
15. Zabriskie D., Wareheim D., and Polanski M. Effects of fermentation feeding strategies prior to induction of expression of a recombinant malaria antigen in Escherichia coli. Ind. Microbiol. 2 (1987) 87-95
16. Nakagawa S., Oda H., and Anazawa H. High cell density cultivation and high recombinant protein production of Escherichia coli strain expressing uricase. Biosci. Biotechnol. Biochem. 59 (1995) 2263-2267
17. Korz D., Hellmurh R., Sanders E., and Deckwer W. Simple fed-batch technique for high cell density cultivation of Escherichia coli. Biotechnol. 39 (1995) 59-65
18. Diogo M., Queiroz J., Monteiro G., Martins S., Ferreira G., and Prazeres D. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol. Bioeng. 68 (2000) 576-583
19. Drew D., Lighttowlers M., and Strugnell R. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taeniaovis 45W antigen. Vaccine 18 (2000) 2522-2532
20. O'Kennedy R., Baldwin C., and Keshavarz-Moore E. Effect of growth medium selection on plasmid DNA production and initial processing step. Biotechnology 76 (2000) 175-183
21. Carnes A.E., Hodgson C.P., and Williams J.A. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol. Appl. Biochem. 45 (2006) 155-166
22. ™ enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines. Vaccine 24 (2006) 1921-1927